Supriya Lifescience Limited (SUPRIYA.BO)
INR 756.75
(-0.05%)
INR 756.75
(-0.05%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -694.68 Million INR | -10.65% |
| 2022 | -627.84 Million INR | 54.62% |
| 2021 | -1.38 Billion INR | -582.17% |
| 2020 | 286.95 Million INR | -65.42% |
| 2019 | 829.77 Million INR | -8.45% |
| 2018 | 906.38 Million INR | -28.99% |
| 2017 | 1.27 Billion INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -772.14 Million INR | 0.0% |
| 2024 Q1 | - INR | 100.0% |
| 2023 Q1 | 1.57 Billion INR | 350.99% |
| 2023 Q3 | 1.15 Billion INR | 217.85% |
| 2023 Q2 | -982.7 Million INR | -162.36% |
| 2023 FY | -694.68 Million INR | -10.65% |
| 2023 Q4 | -694.68 Million INR | -159.99% |
| 2022 Q2 | -924.34 Million INR | -139.51% |
| 2022 Q1 | 2.33 Billion INR | 269.08% |
| 2022 FY | -627.84 Million INR | 54.62% |
| 2022 Q3 | 1.89 Billion INR | 305.09% |
| 2022 Q4 | -627.84 Million INR | -133.12% |
| 2021 Q3 | - INR | -100.0% |
| 2021 FY | -1.38 Billion INR | -582.17% |
| 2021 Q2 | 705.33 Million INR | 0.0% |
| 2021 Q4 | -1.38 Billion INR | 0.0% |
| 2020 Q4 | 286.95 Million INR | -51.88% |
| 2020 FY | 286.95 Million INR | -65.42% |
| 2020 Q3 | 596.27 Million INR | 0.0% |
| 2019 FY | 829.77 Million INR | -8.45% |
| 2018 FY | 906.38 Million INR | -28.99% |
| 2017 FY | 1.27 Billion INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 1.35 Billion INR | 151.276% |
| Biocon Limited | 140.18 Billion INR | 100.496% |
| Blue Jet Healthcare Limited | -830.93 Million INR | 16.397% |
| Concord Biotech Limited | -372.86 Million INR | -86.307% |
| Dishman Carbogen Amcis Limited | 18.99 Billion INR | 103.658% |
| FERMENTA BIOTECH LIMITED | 1.1 Billion INR | 162.9% |
| GENOMIC VALLEY BIOTECH LIMITED | -60.73 Thousand INR | -1143707.423% |
| Lyka Labs Limited | 527.01 Million INR | 231.815% |
| Panacea Biotec Limited | -1.18 Billion INR | 41.372% |
| SAMSRITA LABS LIMITED | 21.98 Million INR | 3259.176% |
| Servoteach Industries Limited | 5016.00 INR | 13849382.297% |
| SMS Lifesciences India Limited | 992.31 Million INR | 170.006% |
| Syngene International Limited | -83 Million INR | -736.964% |
| TAKE Solutions Limited | 361.37 Million INR | 292.235% |
| Titan Biotech Limited | 54.62 Million INR | 1371.656% |
| Transgene Biotek Limited | 139.93 Million INR | 596.438% |
| Vanta Bioscience Limited | 607.93 Million INR | 214.27% |